Medical and Pharmaceutical Industry - Market Research Report

In this report, the global Interventional Cardiovascular Device market is valued at USD 20 million in 2016 and is expected to reach USD 20 million by the end of 2022, growing at a CAGR of 20% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Interventional Cardiovascular Device in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Download full research Report @ http://www.radiantinsights.com/research/global-interventional-cardiovascular-device-industry-2017 Global Interventional Cardiovascular Device market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including GE Healthcare Boston Scientific Philips Volcano Therapeutics Argon Medical Spectranetics Angio Dynamics AccessClosure Merit Medical Systems B...

In this report, the global Cranial Closure and Fixation Devices market is valued at USD 20 million in 2016 and is expected to reach USD 20 million by the end of 2022, growing at a CAGR of 20% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Cranial Closure and Fixation Devices for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Cranial Closure and Fixation Devices market competition by top manufacturers/players, with Cranial Closure and Fixation Devices sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Biomet Johnson & Johnson B Braun Melsungen AG Medtronic Integra LifeSciences Corporation Download full research Report @ http://www.radiantinsights.com/research/global-cranial-closure-and-fixation-devices-sales...

In this report, the global Medical LINAC market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Medical LINAC for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Medical LINAC market competition by top manufacturers/players, with Medical LINAC sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Varian Elekta ACCURAY Sameer Mitsubishi Heavy Industries (MHI) SHANDONG XINHUA MEDICAL INSTRUMENT CO.,LTD Download full research Report @ http://www.radiantinsights.com/research/global-medical-linac-sales-market-report-2017 On the basis of product, this report displays the sales volume (K Units), rev...

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy - Pipeline Review, H1 2017, provides an overview of the Ragweed Pollen Allergy (Immunology) pipeline landscape. Ragweed allergy occurs when ragweed pollen in the air enters the nose and throat of people who are allergic to that pollen, it can cause allergy and asthma symptoms. Symptoms include sneezing, runny or stuffy nose, itchy throat or inside of ears, hives, and swollen eyelids and itchy eyes. Treatment includes decongestant, antihistamine and nasal corticosteroid. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Ragweed Pollen Allergy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Ragweed Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers th...

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Batten Disease - Pipeline Review, H1 2017, provides an overview of the Batten Disease (Central Nervous System) pipeline landscape. Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic disorders known as the neuronal ceroid lipofuscinoses. Symptoms of Batten disease usually become apparent between five and 15 years of age. Symptoms include vision loss, lack of muscle coordination, mental retardation or decreasing mental function, emotional disturbances, seizures, muscle spasms, deterioration of muscle tone and movement problems. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Batten Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Batten Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of ...